Finch Therapeutics Group, Inc. ( FNCH) - Stock Earnings
FNCH Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
FNCH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -63.9 million USD | 107000 USD |
| 2023Q2 | -7.0 million USD | — USD |
| 2023Q3 | -2.4 million USD | — USD |
FNCH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -55.9 million USD | 18.5 million USD |
| 2022 | -113.7 million USD | 861000 USD |
| 2023 | -98.7 million USD | 115000 USD |
| 2026 Est. | — | — |
FNCH
Price: $10.20
52 week price:
Earnings Per Share: -8.80 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 136300
Market Capitalization: 14.8 million